Interview: Evolving And Expanding Global Consulting With Local Expertise

In an insightful discussion, Cencora executives explore the challenges and strategies for global market expansion in the pharmaceutical industry. They highlight the necessity of integrating local expertise with global insights to navigate regulatory landscapes and establish effective market presence.

Kirsten Jacobs stresses the importance of understanding and complying with local regulations, ensuring product development aligns with specific market requirements. Companies must consider clinical strategy, data generation, and Good Practices (GXP) compliance to meet evolving global standards.

Herbert Altmann discusses the European regulatory landscape, including the Health Technology Assessment (HTA) regulation, which streamlines approvals and enhances patient access to innovative medicines. Manufacturers must prepare centralized filings with the European Medicines Agency (EMA) and navigate country-specific pricing and reimbursement processes.

Regarding product lifecycle management, Jacobs emphasizes long-term investments in regulatory and clinical development strategies, monitoring evolving regulations, and adapting compliance frameworks. Drug lifecycles span decades, requiring continuous adjustments to data collection, safety monitoring, and pharmacovigilance processes to maintain global market access.

Cencora’s expertise helps pharmaceutical and biotech firms efficiently launch products across diverse markets, leveraging regulatory insights and strategic planning.